Clinical and microbiological characterization of KPCproducing Klebsiella pneumoniae infections in Brazil

Paterson, 2005, Extended-Spectrum β-Lactamases: a Clinical Update, Clinical Microbiology Reviews, 18, 657, 10.1128/CMR.18.4.657-686.2005 Nordmann, 2009, The real threat of Klebsiella pneumoniae carbapenemase producing bacteria, Lancet Infect Dis, 9, 228, 10.1016/S1473-3099(09)70054-4 Arias, 2009, Antibiotic-Resistant Bugs in the 21st Century — A Clinical Super-Challenge, N Engl J Med, 360, 439, 10.1056/NEJMp0804651 Yigit, 2001, Novel carbapenemhydrolyzing beta-lactamase, KPC-1, from a carbapenemresistant strain of Klebsiella pneumoniae, Antimicrob Agents Chemother, 45, 1151, 10.1128/AAC.45.4.1151-1161.2001 Bratu, 2007, Detection and spread of Escherichia coli possessing the plasmid-borne carbapenemase KPC-2 in Brooklyn, New York. Clin Infect Dis, 44, 972, 10.1086/512370 Leavitt, 2007, Emergence of KPC-2 and KPC-3 in carbapenem-resistant Klebsiella pneumoniae strains in an Israeli hospital, Antimicrob. Agents Chemother, 51, 3026, 10.1128/AAC.00299-07 Wei, 2007, Plasmid-mediated KPC-2 in a Klebsiella pneumoniae isolate from China, Antimicrob Agents Chemother, 51, 763, 10.1128/AAC.01053-06 Cuzon, 2008, Plasmid-mediated carbapenem- hydrolyzing β-lactamase KPC in Klebsiella pneumoniae isolate from Greece, Antimicrob Agents Chemother, 52, 796, 10.1128/AAC.01180-07 Villegas, 2006, First detection of the plasmid-mediated class A carbapenemase KPC-2 in clinical isolates of Klebsiella pneumoniae from South America, Antimicrob Agents Chemother, 50, 2880, 10.1128/AAC.00186-06 Monteiro, 2008, First report of KPC- 2-producing-Klebsiella pneumoniae in Brazil, Antimicrob Agents Chemother, 53, 333, 10.1128/AAC.00736-08 Peirano, 2009, Carbapenem hydrolysing β-lactamase KPC-2 in Klebsiella pneumoniae isolated in Rio de Janeiro, Brazil, J Antimicrob Chemother, 63, 265, 10.1093/jac/dkn484 Pavez, 2008, Emergence of carbapenemresistant Escherichia coli producing CMY-2-type AmpC betalactamase in Brazil, J Med Microbiol, 57, 1590, 10.1099/jmm.0.2008/002774-0 Garibaldi, 1974, Factors predisposing to bacteriuria during indwelling urethral catheterisation, The New England Journal of Medicine, 291, 213, 10.1056/NEJM197408012910501 Stephen, 2008, Calfee, Outcomes of Carbapenem- Resistant Klebsiella pneumoniae Infection and the Impact of Antimicrobial and Adjunctive Therapies, Infect Control Hosp Epidemiol, 29, 1099, 10.1086/592412 Weisenberga, 2009, Clinical outcomes of patients with Klebsiella pneumoniae carbapenemase-producing K. pneumoniae after treatment with imipenem or meropenem, Diagnostic Microbiology and Infectious Disease, 64, 233, 10.1016/j.diagmicrobio.2009.02.004 Landman, 2008, Polymyxins Revisited, Clinical Microbiology Reviews, 21, 449, 10.1128/CMR.00006-08 Hawkey, 2007, Tigecycline: in-vitro performance as a predictor of clinical efficacy, Clin Microbiol Infect, 13, 354, 10.1111/j.1469-0691.2006.01621.x Castanheira, 2008, Antimicrobial activities of tigecycline and other broad-spectrum antimicrobials tested against serine carbapenemase- and metallo-beta-lactamase-producing enterobacteriaceae: Report from the SENTRY antimicrobial surveillance program, Antimicrobial Agents and Chemotherapy, 52, 570, 10.1128/AAC.01114-07 Anthony, 2008, Clinical and Microbiological Outcomes of Serious Infections with Multidrug- Resistant Gram-Negative Organisms Treated with Tigecycline, Clinical Infectious Diseases, 46, 567, 10.1086/526775 Nicasio, 2009, In vivo Pharmacodynamic Profile of Tigecycline against Phenotypically Diverse Escherichia coli and Klebsiella pneumoniae Isolates, Antimicrobial Agents and Chemotherapy, 53, 2756, 10.1128/AAC.01678-08